Main content

Dacarba LLC Launches Medical Diagnosis Accuracy Reporting (MDAR) Technology Solution

Dacarba LLC, an Opportune LLP company, is pleased to announce that it has launched a proprietary data-driven prescriptive analytics software, Medical Diagnosis Accuracy Reporting (MDAR), which paints an accurate and transparent picture of each patient’s comorbidities for providers and improves quality measurement.

The technology solution creates an equal playing field across healthcare institutions, accurately reflects the quality of care provided and strengthens physician and hospital credibility.

American healthcare is undergoing a transformation from fee-for-service to outcomes and value, with an ever-increasing emphasis on quality, safety and value-based payments. Quality performance metrics are used more and more to drive value-based payments and reputation for providers and hospitals. Healthcare systems across the nation desire to improve their overall rankings by accurately reflecting clinical quality and anticipate continued industrywide changes.

MDAR focuses on the accuracy of medical diagnosis by identifying complication or comorbidities for one or more of the chronic and acute conditions identified by the Center for Medicare & Medicaid Services as clinical areas of importance. A comprehensive dataset is generated daily. Clinical variables are identified and analyzed for each condition to identify possible quality improvement.

MDAR is a technology solution that facilitates collaboration to maximize value across the organization while adding value to financial, reputational and operational areas across a facility or system.

“We are excited and committed to be an influential agent associated with quality in the U.S. healthcare landscape,” said Sean Clements, Managing Partner of Dacarba. “MDAR is a proven, powerful tool that effectively maximizes the true quality rating of hospitals across all major rating organizations.”

Chris Hudson, Head of Dacarba’s Healthcare practice, added: “The system by which hospital quality is measured and reported is opaque and ever-evolving. We are committed to bring transparency to quality ratings and MDAR stands alone in being able to deliver that promise.”

About Dacarba LLC

Dacarba LLC is a professional services firm headquartered in New York City. Dacarba works with management teams, boards of directors and other key stakeholders to navigate complex and challenging assignments and provide clients with comprehensive solutions. The firm’s core service offerings include: complex financial reporting, healthcare technology, litigation support and financial advisory, process and technology, restructuring, strategy and organization, tax and valuation. To learn more about Dacarba, please visit www.dacarba.com.

About Opportune

Opportune LLP is a leading global energy business advisory firm specializing in adding value to clients across the energy industry, including upstream, midstream, downstream, power and gas, commodities trading and oilfield services. Opportune’s service lines include: complex financial reporting, dispute resolution, enterprise risk, investment banking, outsourcing, process and technology, reserve engineering and geosciences, restructuring, strategy and organization, tax, transactional due diligence and valuation. For more information on Opportune LLP, please visit our website at www.opportune.com.

 

Sean ClementsManaging Partner

Sean has experience guiding clients through complex situations such as financial restructurings, business interruption claims and other damages and litigation matters requiring a financial expert. Sean has worked across the entire energy spectrum and in the manufacturing space.

Chris HudsonManaging Director

Chris leads Dacarba's Healthcare practice bringing over 25 years of experience across both consulting and industry. He has guided companies through transformations, strategy creation, operational, financial and technology improvements. Chris has worked across the payor, provider and life sciences industries.